Radiation treatment of the liver for malignant disease has gained renewed i
nterest due to newly developed treatment modalities. Still limited specific
knowledge is available concerning liver damage following irradiation. Inco
nsistencies between reported animal experimental studies are largely due to
differences in irradiation techniques and to varying Observation periods.
Following the introduction of Megavoltage irradiation and the development o
f more sophisticated irradiation techniques, clinical reports concerning mo
re reliable studies became available. The reaction of the fiver to irradiat
ion depends specifically on parameters as type of irradiation, dose, dose r
ate, fractionation schedule, and irradiated volume. Also the use of cytotox
ic agents and liver surgery are of importance for the ultimate therapeutic
result.
Radiation hepatitis in humans may develop following high-dose liver irradia
tion resulting in clinical and histopathological disorders resembling a ven
o-occlusive disease-like syndrome. These disorders may either totally or pa
rtially recover or be progressive in time resulting in hepatic failure.
It is concluded that depending on the variables mentioned, ionizing radiati
on up to 35 Gy to the human liver, given to a limited volume, can be applie
d without major liver function disturbances.